Jump Financial, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1831577 Chicago, IL

Position in RXRX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,740,364

+$1,008,270 QoQ

Shares Held

1,019,173

+14.5% QoQ

Ownership

0.190%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#32

of 343 holders

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,725,895 across 169 Biotechnology names. RXRX ranks #37 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,740,364	1,019,173	+14.5%	Shares	Defined	2026-08-13
2026-03-31	$2,732,094	889,933	+34.5%	Shares	Defined	2026-05-14
2025-12-31	$2,706,061	661,629	+19.2%	Shares	Defined	2026-02-17
2025-09-30	$2,708,780	555,078	-51.8%	Shares	Defined	2025-11-13
2025-06-30	$5,825,077	1,151,201	+94.3%	Shares	Defined	2025-08-13
2025-03-31	$3,133,546	592,353	+4289.8%	Shares	Defined	2025-05-14
2024-12-31	$91,219	13,494	-94.7%	Shares	Defined	2025-02-13
2023-09-30	$1,938,999	253,464	+2039.1%	Shares	Sole	2024-10-21
2023-06-30	$88,511	11,849	-90.9%	Shares	Sole	2024-10-21
2023-03-31	$864,038	129,541	—	Shares	Sole	2024-10-21
No filing history on record for this holder in this stock.